Treatment of Anismus
Biofeedback therapy is the first-line treatment for anismus, with combination therapy of acupoint thread embedding plus biofeedback showing superior short-term outcomes, though surgical intervention with partial division of puborectalis muscle combined with lateral internal sphincterotomy should be considered for patients who fail conservative management after 3-6 months. 1, 2, 3
First-Line Conservative Management
Biofeedback Therapy (BFT)
- Biofeedback is the established first-line treatment for anismus, a defecation disorder characterized by paradoxical contraction or failure to relax the puborectalis muscle during attempted defecation 1, 4
- Standard biofeedback achieves clinical improvement in approximately 50% of patients at 1 month, though this drops to only 30% at 1 year 2
- Patients with symptom duration less than 3 years respond significantly better to biofeedback than those with longer symptom duration (33 ± 34 months vs 81 ± 61 months for non-responders, p < 0.01) 4
- The presence of associated pelvirectal disorders (rectocele, rectal prolapse, abnormal perineal descent) does not predict biofeedback failure, so extensive pre-treatment imaging is not mandatory 4
Enhanced Biofeedback Approaches
- Psycho-echo-biofeedback combining guided imagery, relaxation techniques, and ultrasound-assisted biofeedback allows all patients to achieve physiological puborectalis relaxation during the treatment session 5
- This approach is particularly valuable for patients with concurrent anxiety or depression 5
- Previous anorectal surgery is a negative predictor of biofeedback success and should prompt earlier consideration of alternative treatments 5
Combination Therapy with Acupoint Thread Embedding
- The combination of acupoint thread embedding (ATE) plus biofeedback demonstrates significantly superior outcomes compared to either therapy alone, with an 85% total effectiveness rate versus 68.89% for biofeedback alone (p = 0.03) 1
- At 3-month post-treatment, combination therapy produces significantly lower constipation scores, traditional Chinese medicine syndrome scores, and quality of life impairment compared to biofeedback monotherapy 1
- Benefits persist at 3-month follow-up but return to baseline by 6 months, indicating need for maintenance therapy 1
Second-Line Pharmacologic Treatment
Botulinum Toxin Type A Injection
- Botulinum toxin injection into the puborectalis muscle achieves 75% clinical improvement at 1 month but only 35% at 1 year, making it effective for temporary relief but not durable long-term treatment 2
- This approach is appropriate for patients who fail biofeedback but wish to avoid surgery 2
- The injection provides a therapeutic window to attempt additional biofeedback retraining 2
Surgical Management
Indications for Surgery
- Surgery should be considered for patients who remain symptomatic after 3-6 months of conservative treatment failure 2, 3
- Patients with anal hypertonia-associated anismus are particularly appropriate surgical candidates 3
Surgical Technique
- Partial division of puborectalis muscle combined with tailored lateral internal sphincterotomy on the contralateral side is the most effective surgical approach, achieving 89% symptom improvement at 12 months 3
- This combined technique produces significant reduction in modified Altomare constipation scores from 16.4 ± 1.7 to 6.6 ± 1.0 at 12 months (p < 0.0001) 3
- Surgical outcomes are superior to both biofeedback (70% vs 30% success at 1 year) and botulinum toxin (70% vs 35% success at 1 year) 2
- Complication rate is low at 6.5%, with only minor complications reported 3
Treatment Algorithm
Initial 3-month trial of biofeedback therapy for all patients 1, 2
If symptoms persist after 3 months of biofeedback:
Surgical intervention if conservative measures fail after 3-6 months:
- Partial division of puborectalis muscle with contralateral lateral internal sphincterotomy 3
Critical Pitfalls to Avoid
- Do not delay treatment in patients with symptom duration exceeding 3 years, as biofeedback success rates decline significantly with longer symptom duration 4
- Do not rely solely on botulinum toxin for long-term management, as efficacy drops dramatically after 1 year 2
- Previous anorectal surgery significantly reduces biofeedback success, warranting earlier consideration of surgical options in these patients 5
- Do not perform extensive pre-treatment imaging to identify associated pelvirectal disorders, as their presence does not predict biofeedback failure 4